| Title |
DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
|
|---|---|
| Published in |
Respiratory Research, October 2020
|
| DOI | 10.1186/s12931-020-01541-7 |
| Pubmed ID | |
| Authors |
Andrew Menzies-Gow, Sandhia Ponnarambil, John Downie, Karin Bowen, Åsa Hellqvist, Gene Colice |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 91 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 14% |
| Other | 9 | 10% |
| Student > Ph. D. Student | 6 | 7% |
| Student > Master | 6 | 7% |
| Student > Doctoral Student | 6 | 7% |
| Other | 22 | 24% |
| Unknown | 29 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 30% |
| Nursing and Health Professions | 10 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Unspecified | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Other | 11 | 12% |
| Unknown | 32 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 February 2023.
All research outputs
#2,761,775
of 25,387,668 outputs
Outputs from Respiratory Research
#316
of 3,063 outputs
Outputs of similar age
#70,729
of 439,197 outputs
Outputs of similar age from Respiratory Research
#14
of 93 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,063 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,197 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.